Skin Tech Pharma Group Wins Best Injectable at AMWC 2026
BARCELONA, Spain, June 17, 2026 Skin Tech Pharma Group has announced that its flagship injectable treatment, RRSĀ® HA LONG...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
BARCELONA, Spain, June 17, 2026 Skin Tech Pharma Group has announced that its flagship injectable treatment, RRSĀ® HA LONG...
IRVINE, Calif., June 16, 2026 Allergan Aesthetics, an AbbVie company, has received U.S. Food and Drug Administration (FDA) approval...
North Chicago, Illinois, USA ā May 21, 2026 Allergan Aesthetics, an AbbVie company and global leader in medical aesthetics,...
New Taipei City, Taiwan ā May 22, 2026 Caliway Biopharmaceuticals has announced a major milestone for its innovative injectable...
ROCKVILLE, Md. ā May 8, 2026 AAVnerGene Inc. announced the launch of AAVoneĀ®2.1, the next-generation evolution of its proprietary...
YOKNEAM, Israel ā May 8, 2026 Lumenis announced that its groundbreaking hair restoration platform FoLix⢠has received the Hair...
Paris, France, April 7, 2026 Global Contracts Strengthen Aesthetic Market Leadership In a major development for the global aesthetic...
